Entrada Therapeutics
TRDA
#6020
Rank
C$1.04 B
Marketcap
$27.97
Share price
0.86%
Change (1 day)
23.63%
Change (1 year)

P/S ratio for Entrada Therapeutics (TRDA)

P/S ratio as of November 2024 (TTM): 3.12

According to Entrada Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.77. At the end of 2024 the company had a P/S ratio of 2.01.

P/S ratio history for Entrada Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20242.01-48.51%
20233.90
2022N/A
2021N/A